A detailed history of Westchester Capital Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Westchester Capital Management, LLC holds 1,352,210 shares of AXNX stock, worth $93.2 Million. This represents 3.73% of its overall portfolio holdings.

Number of Shares
1,352,210
Previous 1,143,773 18.22%
Holding current value
$93.2 Million
Previous $78.9 Million 15.24%
% of portfolio
3.73%
Previous 3.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $13.9 Million - $14.5 Million
208,437 Added 18.22%
1,352,210 $90.9 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $64.8 Million - $79.3 Million
1,143,773 New
1,143,773 $78.9 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.38B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Westchester Capital Management, LLC Portfolio

Follow Westchester Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westchester Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westchester Capital Management, LLC with notifications on news.